Transcat, Inc. (NASDAQ:TRNS) Receives Consensus Recommendation of “Moderate Buy” from Analysts

Transcat, Inc. (NASDAQ:TRNSGet Free Report) has been assigned a consensus recommendation of “Moderate Buy” from the eight analysts that are presently covering the firm, MarketBeat.com reports. Three research analysts have rated the stock with a hold rating, three have assigned a buy rating and two have issued a strong buy rating on the company. The average 12-month price objective among brokerages that have updated their coverage on the stock in the last year is $110.25.

Several equities research analysts recently issued reports on the company. HC Wainwright reiterated a “buy” rating and issued a $116.00 price objective on shares of Transcat in a report on Friday, August 22nd. Northland Securities set a $95.00 target price on shares of Transcat in a research report on Thursday, October 23rd. Zacks Research upgraded shares of Transcat from a “hold” rating to a “strong-buy” rating in a research report on Tuesday, October 7th. Northland Capmk upgraded shares of Transcat from a “hold” rating to a “strong-buy” rating in a report on Thursday, October 23rd. Finally, Weiss Ratings restated a “hold (c-)” rating on shares of Transcat in a report on Wednesday, November 5th.

Read Our Latest Research Report on TRNS

Transcat Trading Down 3.7%

Shares of TRNS stock opened at $56.59 on Wednesday. Transcat has a 1-year low of $54.10 and a 1-year high of $112.22. The company has a market cap of $527.87 million, a price-to-earnings ratio of 39.57 and a beta of 0.71. The company has a debt-to-equity ratio of 0.11, a current ratio of 2.92 and a quick ratio of 2.36. The stock has a 50 day simple moving average of $71.87 and a 200-day simple moving average of $78.99.

Transcat (NASDAQ:TRNSGet Free Report) last posted its quarterly earnings data on Monday, November 3rd. The scientific and technical instruments company reported $0.44 earnings per share for the quarter, missing analysts’ consensus estimates of $0.46 by ($0.02). The company had revenue of $82.27 million for the quarter, compared to analyst estimates of $79.51 million. Transcat had a return on equity of 6.66% and a net margin of 4.64%. On average, equities research analysts expect that Transcat will post 2.3 EPS for the current fiscal year.

Institutional Inflows and Outflows

A number of large investors have recently added to or reduced their stakes in TRNS. State of Alaska Department of Revenue acquired a new stake in Transcat during the third quarter worth $40,000. Lazard Asset Management LLC acquired a new stake in shares of Transcat during the 2nd quarter worth about $54,000. Parkside Financial Bank & Trust acquired a new stake in shares of Transcat during the 2nd quarter worth about $79,000. Quantbot Technologies LP purchased a new stake in Transcat in the 1st quarter valued at about $76,000. Finally, PNC Financial Services Group Inc. boosted its stake in Transcat by 1,118.2% during the second quarter. PNC Financial Services Group Inc. now owns 1,072 shares of the scientific and technical instruments company’s stock worth $92,000 after buying an additional 984 shares during the period. 98.34% of the stock is currently owned by institutional investors and hedge funds.

Transcat Company Profile

(Get Free Report)

Transcat, Inc provides calibration and laboratory instrument services in the United States, Canada, and internationally. It operates through two segments: Service and Distribution. The Service segment offers calibration, repair, inspection, analytical qualification, preventative maintenance, consulting, and other related services.

Read More

Analyst Recommendations for Transcat (NASDAQ:TRNS)

Receive News & Ratings for Transcat Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Transcat and related companies with MarketBeat.com's FREE daily email newsletter.